Renalytix Plc (AIM:RENX)
London
· Delayed Price · Currency is GBP · Price in GBX 7.25
-0.05 (-0.69%)
Jun 27, 2025, 4:35 PM GMT+1
Renalytix Market Cap
Renalytix has a market cap or net worth of 24.01 million as of June 27, 2025. Its market cap has decreased by -19.19% in one year.
Market Cap
24.01M
Enterprise Value
22.88M
Revenue
2.31M
Ranking
n/a
PE Ratio
n/a
Stock Price
7.25
Market Cap Chart
Since November 6, 2018, Renalytix's market cap has decreased from 64.58M to 24.01M, a decrease of -62.82%. That is a compound annual growth rate of -13.84%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 160.21B |
| GSK plc | 56.45B |
| Haleon | 34.40B |
| Smith & Nephew | 9.56B |
| ConvaTec Group | 5.91B |
| Hikma Pharmaceuticals | 4.55B |
| HUTCHMED (China) | 1.97B |
| Genus | 1.28B |